The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings
CNBC • U.S. • 1 hour ago
As Lilly widens its lead in the obesity race, Novo is still racing to win back market share and restore investor confidence in its pipeline.
Related News
Insults, Expletives and Fat-Shaming: Vance Trolls Critics on the Right and Left
The vice president has dispensed with the decorum and restraint of his predecessors to directly take on opponents and j…
Trump administration moves forward with Head Start overhaul, proposing to eliminate regulations
President Donald Trump’s administration plans to overhaul Head Start, a key early education program for the nation's po…
What Is Fauci Being Accused of and Why Is He Being Held in Contempt?
The case is unique, legal scholars say, because of the tension between the Fifth Amendment and the reach of a president…
How Fauci Got to This Point and the Legal Peril He Faces
The case is unique, legal scholars say, because of the tension between the Fifth Amendment and the reach of a president…
Tennessee’s Andy Ogles Faces Well-Funded Opposition in House Primary Thursday
Representative Andy Ogles received President Trump’s endorsement, but his challenger, Charlie Hatcher, a former state a…
Fox won't renegotiate NFL media rights before current deal expires, CEO Lachlan Murdoch says
Fox has decided not to renegotiate its current TV deal with the NFL until the expiration of the league's opt-out clause…
CNBC
• 53 minutes ago